Preston K L, Silverman K, Schuster C R, Cone E J
Clinical Trials Section, National Institute on Drug Abuse, Baltimore, MD 21224, USA.
NIDA Res Monogr. 1997;167:130-45.
The effectiveness of substance abuse treatment programs can be monitored by self-reported drug use and objectively measured by qualitative and quantitative urinalysis. The advantages and disadvantages of each of these three methods of assessing drug use are reviewed. Data collected in a clinical trial of a behavioral treatment for cocaine abuse are used to evaluate the relationships among qualitative and quantitative urinalysis for cocaine metabolite and self-reported cocaine use. Qualitative and quantitative urine testing showed greater rates of drug use than that shown by self-report, though there were significant correlations between self-reported use and urine toxicology results. Benzoylecgonine concentrations in urine specimens supported the suggestions that rates of drug use as determined by qualitative urinalysis are artificially high due to carryover and were informative about subjects' patterns of use.
药物滥用治疗项目的有效性可以通过自我报告的药物使用情况进行监测,并通过定性和定量尿液分析进行客观测量。本文回顾了这三种评估药物使用方法各自的优缺点。在一项针对可卡因滥用的行为治疗临床试验中收集的数据,用于评估可卡因代谢物的定性和定量尿液分析与自我报告的可卡因使用之间的关系。定性和定量尿液检测显示的药物使用率高于自我报告显示的使用率,尽管自我报告的使用情况与尿液毒理学结果之间存在显著相关性。尿液标本中的苯甲酰爱康宁浓度支持了以下观点:定性尿液分析确定的药物使用率因残留而人为偏高,并且能提供有关受试者使用模式的信息。